Skip to main content
. 2016 Feb 1;11(2):e0148184. doi: 10.1371/journal.pone.0148184

Fig 10. Titers of neutralizing antibodies against SAFV-3 in sera from young BALB/c mice.

Fig 10

On Day 21 post-inoculation, sera were obtained from mice inoculated intracerebrally (ic), intraperitoneally (ip), intravenously (iv), orally (po), or intranasally (in) with the aseptic meningitis (AM) or upper respiratory (UR) strains of SAFV-3 (n = 4 or 6 mice per group). All mice inoculated with the UR strain, but not those inoculated with the AM strain, via the oral or intranasal routes, generated neutralizing antibodies.